Scientists may have been unknowingly inflating microplastics pollution estimates, and the surprising source could be their own lab gloves. A University of Michigan study found that common nitrile and ...

SEATTLE — Every day, we hear more ways artificial intelligence is being integrated into our lives. We have seen AI for years, like when Netflix has an automated list of suggested movies or shows. But ...

For more than 20 years, the anatomy lab at Drexel University College of Medicine has engaged in outreach to local high schools, colleges, and universities. The program began as a grassroots effort in ...

Measles cases have topped 1,000 in the United States for the third time in 26 years. At least 154 new measles cases have been confirmed in the last week for a total of 1,136, according to updated data ...

DIY store chain ManoMano is notifying customers of a data breach that was caused by hackers compromising a third-party service provider. The company confirmed to BleepingComputer that it learned of ...

The Bachelor of Science in Data Analytics is a new interdisciplinary program designed to prepare you with the skills to collect, manage, analyze and interpret complex data. Building on foundations in ...

Opentrons is using Nvidia’s Isaac and Cosmos artificial intelligence (AI) platforms to generate training data needed to develop and deploy physical AI-enabled laboratory robotics. The company’s goal ...

Research analyzing 4,700 leading websites reveals that 64% of third-party applications now access sensitive data without business justification, up from 51% in 2024. Government sector malicious ...

It takes a lot to shock me anymore. I’ve covered Washington government for years. I understand rounding errors. I get that numbers shift, estimates change, projections don’t always pan out. That’s ...

Samuel Hardiman is an enterprise reporter who focuses on government and politics. He began his career at the Tulsa World where he covered business and K-12 education. Hardiman came to Memphis in 2018 ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...